|
1
|
Kinsler VA, O'Hare P, Bulstrode N, Calonje
JE, Chong WK, Hargrave D, Jacques T, Lomas D, Sebire NJ and Slater
O: Melanoma in congenital melanocytic naevi. Br J Dermatol.
176:1131–1143. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Krengel S, Scope A, Dusza SW, Vonthein R
and Marghoob AA: New recommendations for the categorization of
cutaneous features of congenital melanocytic nevi. J Am Acad
Dermatol. 68:441–451. 2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Marghoob AA, Swindle LD, Moricz CZ,
Sanchez Negron FA, Slue B, Halpern AC and Kopf AW: Instruments and
new technologies for the in vivo diagnosis of melanoma. J Am Acad
Dermatol. 49:777–799. 2003.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Haenssle HA, Fink C, Schneiderbauer R,
Toberer F, Buhl T, Blum A, Kalloo A, Hassen ABH, Thomas L, Enk A,
et al: Man against machine: Diagnostic performance of a deep
learning convolutional neural network for dermoscopic melanoma
recognition in comparison to 58 dermatologists. Ann Oncol.
29:1836–1842. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Raimondi S, Sera F, Gandini S, Iodice S,
Caini S, Maisonneuve P and Fargnoli MC: MC1R variants, melanoma and
red hair color phenotype: A meta-analysis. Int J Cancer.
122:2753–2760. 2008.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Tagliabue E, Gandini S, Bellocco R,
Maisonneuve P, Newton-Bishop J, Polsky D, Lazovich D, Kanetsky PA,
Ghiorzo P, Gruis NA, et al: MC1R variants as melanoma risk factors
independent of at-risk phenotypic characteristics: a pooled
analysis from the M-SKIP project. Cancer Manag Res. 10:1143–1154.
2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Richards S, Aziz N, Bale S, Bick D, Das S,
Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al:
Standards and guidelines for the interpretation of sequence
variants: A joint consensus recommendation of the American college
of medical genetics and genomics and the association for molecular
pathology. Genet Med. 17:405–424. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Viana AC, Gontijo B and Bittencourt FV:
Giant congenital melanocytic nevus. An Bras Dermatol. 88:863–878.
2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Arneja JS and Gosain AK: Giant congenital
melanocytic nevi of the trunk and an algorithm for treatment. J
Craniofac Surg. 16:886–893. 2005.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Meshram GG, Kaur N and Hura KS: Giant
congenital melanocytic nevi: An update and emerging therapies. Case
Rep Dermatol. 10:24–28. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kopf AW, Bart RS and Hennessey P:
Congenital nevocytic nevi and malignant melanomas. J Am Acad
Dermatol. 1:123–130. 1979.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Krengel S, Hauschild A and Schäfer T:
Melanoma risk in congenital melanocytic naevi: a systematic review.
Br J Dermatol. 155:1–8. 2006.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Viana ACL, Goulart EMA, Gontijo B and
Bittencourt FV: A prospective study of patients with large
congenital melanocytic nevi and the risk of melanoma. An Bras
Dermatol. 92:200–205. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Barcaui C, Bakos RM, Paschoal FM,
Bittencourt FV, de Sá BCS and Miot HA: Total body mapping in the
follow-up of melanocytic lesions: Recommendations of the Brazilian
society of dermatology. An Bras Dermatol. 96:472–476.
2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Torres-Mora J, Dry S, Li X, Binder S, Amin
M and Folpe AL: Malignant melanotic schwannian tumor: a
clinicopathologic, immunohistochemical, and gene expression
profiling study of 40 cases, with a proposal for the
reclassification of "melanotic schwannoma". Am J Surg Pathol.
38:94–105. 2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ranson M, Lai J, Van Brenk B, McCalmont TH
and Walsh NM: Plexiform melanocytic schwannoma: Report of a second
case and overview of a rare entity. Am J Dermatopathol. 44:943–947.
2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Sturm RA: Skin colour and skin
cancer-MC1R, the genetic link. Melanoma Res. 12:405–416.
2002.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Cai M and Hruby VJ: The melanocortin
receptor system: A target for multiple degenerative diseases. Curr
Protein Pept Sci. 17:488–96. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Roberts DW, Newton RA, Beaumont KA,
Leonard JH and Sturm RA: Quantitative analysis of MC1R gene
expression in human skin cell cultures. Pigment Cell Res. 19:76–89.
2006.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Beaumont KA, Liu YY and Sturm RA: The
melanocortin-1 receptor gene polymorphism and association with
human skin cancer. Prog Mol Biol Transl Sci. 88:85–153.
2009.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Pasquali E, García-Borrón JC, Fargnoli MC,
Gandini S, Maisonneuve P, Bagnardi V, Specchia C, Liu F, Kayser M,
Nijsten T, et al: MC1R variants increased the risk of sporadic
cutaneous melanoma in darker-pigmented Caucasians: A
pooled-analysis from the M-SKIP project. Int J Cancer. 136:618–631.
2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Beaumont KA, Shekar SN, Newton RA, James
MR, Stow JL, Duffy DL and Sturm RA: Receptor function, dominant
negative activity and phenotype correlations for MC1R variant
alleles. Hum Mol Genet. 16:2249–2260. 2007.PubMed/NCBI View Article : Google Scholar
|
|
23
|
van der Poel LAJ, Bergman W, Gruis NA and
Kukutsch NA: The role of MC1R gene variants and phenotypical
features in predicting high nevus count. Melanoma Res. 30:511–514.
2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Vallone MG, Tell-Marti G, Potrony M,
Rebollo-Morell A, Badenas C, Puig-Butille JA, Gimenez-Xavier P,
Carrera C, Malvehy J and Puig S: Melanocortin 1 receptor (MC1R)
polymorphisms' influence on size and dermoscopic features of nevi.
Pigment Cell Melanoma Res. 31:39–50. 2018.PubMed/NCBI View Article : Google Scholar
|
